Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05963334
Status:
COMPLETED
Last Update Posted:
2023-07-27
First Post:
2023-07-10
Brief Title:
Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer
Sponsor:
Cairo University
Organization:
Cairo University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Epithelial Ovarian Cancer |
Keywords:
| Name | View |
|---|---|
| Functional assessment of cancer therapygynecologic oncology groupneurotoxicity FACT-GOGNTX | View |
| Carboplatin induced side effects | View |
| Patient safety | View |
| Acute and chronic kidney injury | View |
| Anemia neutropenia and thrombocytopenia | View |
| Advanced epithelia ovarian cancer | View |
| Improved patient toleration | View |
| Patient counselling and education | View |
| Routine laboratory tests and tumor markers comparison | View |
| Additional biomarkers | View |
| Cystatin-C Cys-C | View |
| Neutrophil gelatinase associated lipocalin NGAL | View |
| Interleukin-18 IL-18 | View |
| Hepcidin HEPC | View |
| Kidney injury marker-1 KIM-1 | View |
| Quality of life | View |
| Health related quality of life outcomes | View |
| Progression free survival | View |
| Palliative care | View |
| Chemotherapy surgery and non-pharmacological treatment of ovarian cancer | View |
| Functional assessment of cancer therapy for ovarian cancer FACT-O | View |